Leaders in radiation oncology awarded ASTRO Fellow designation

The American Society for Radiation Oncology (ASTRO) has selected 19 distinguished members to receive the ASTRO Fellow (FASTRO) designation. The 2020 class of Fellows will be recognized at a virtual awards ceremony on October 27 during ASTRO’s 62nd...
23-Jul-2020 8:30 AM EDT Add to Favorites

Dr. Geraldine Jacobson elected as future Chair of the American Society for Radiation Oncology (ASTRO)

The members of the American Society for Radiation Oncology (ASTRO) have elected four new officers to ASTRO’s Board of Directors. Geraldine Jacobson, MD, MPH, MBA, FASTRO, will begin her term as President-elect in October during ASTRO’s 62nd...
22-Jul-2020 1:30 PM EDT Add to Favorites

American Society for Radiation Oncology (ASTRO) to host virtual Annual Meeting, October 25-28

The American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting, will be held October 25-28 via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest...
9-Jul-2020 1:00 PM EDT Add to Favorites

ASTRO Issues First Clinical Guideline on Radiation Therapy for Cervical Cancer

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer. The guideline outlines indications and best practices for EBRT and...
10-Jun-2020 7:50 AM EDT Add to Favorites

ASTRO survey: Fewer patient visits despite enhanced COVID-19 safety measures for radiation oncology clinics

Despite facing challenges such as limited access to PPE during the COVID-19 outbreak, radiation oncology clinics quickly implemented safety enhancements that allowed them to continue caring for cancer patients, according to a new national survey...
20-May-2020 8:00 AM EDT Add to Favorites

Drug used for breast, kidney cancers may also extend survival for patients with advanced head and neck cancer

A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment. Patients enrolled in a randomized...
26-Feb-2020 12:15 PM EST Add to Favorites

Radiation/immunotherapy combo shows promise for recurrent/metastatic head and neck cancers

A new phase II trial finds that a combination of radiation therapy and immunotherapy led to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). The combination of...
26-Feb-2020 8:20 AM EST Add to Favorites

Pre-operative immunotherapy triggers encouraging response in oral cancers

A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients. In the randomized trial, two neoadjuvant...
26-Feb-2020 8:25 AM EST Add to Favorites

See All News